Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1006)
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
828
Price
$15.75
Total Value
$13.04K
Shares Held After
3,935,608
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,000
Price
$87.35
Total Value
$174.70K
Shares Held After
51,542
% of Holdings
3.7%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.89
Total Value
$48.95K
Shares Held After
3,042,000
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,170
Price
$27.38
Total Value
$59.41K
Shares Held After
76,140
% of Holdings
2.8%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
50,000
Price
$3.57
Total Value
$178.50K
Shares Held After
522,551
% of Holdings
8.7%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
2,100
Price
$14.44
Total Value
$30.32K
Shares Held After
429,850
% of Holdings
0.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
16,960
Price
$13.79
Total Value
$233.88K
Shares Held After
431,950
% of Holdings
3.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,800
Price
$75.53
Total Value
$589.12K
Shares Held After
4,418,447
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,128
Price
$74.57
Total Value
$382.38K
Shares Held After
4,426,247
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,072
Price
$73.64
Total Value
$520.80K
Shares Held After
4,431,375
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,500
Price
$75.55
Total Value
$566.66K
Shares Held After
615,686
% of Holdings
1.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,300
Price
$74.60
Total Value
$395.40K
Shares Held After
623,186
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,200
Price
$73.64
Total Value
$530.24K
Shares Held After
628,486
% of Holdings
1.1%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
SUH, DAVID JR. — Chief Accounting Officer
Shares
200
Price
$5.00
Total Value
$1.00K
Shares Held After
111,866
% of Holdings
0.2%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
133,789
Price
$40.24
Total Value
$5.38M
Shares Held After
411,855
% of Holdings
24.5%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$40.12
Total Value
$1.00M
Shares Held After
1,516,667
% of Holdings
1.6%
Kiniksa Pharmaceuticals International, plc (KNSA)
Moat Ross — CHIEF OPERATING OFFICER
Shares
1,703
Price
$46.69
Total Value
$79.51K
Shares Held After
12,029
% of Holdings
12.4%
Kiniksa Pharmaceuticals International, plc (KNSA)
Megna Michael R — CHIEF ACCOUNTING OFFICER
Shares
6,625
Price
$46.69
Total Value
$309.32K
Shares Held After
27,418
% of Holdings
19.5%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
2,597
Price
$49.89
Total Value
$129.56K
Shares Held After
125,694
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
200
Price
$183.00
Total Value
$36.60K
Shares Held After
170,934
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
3,000
Price
$182.40
Total Value
$547.19K
Shares Held After
171,134
% of Holdings
1.7%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
900
Price
$105.00
Total Value
$94.50K
Shares Held After
65,604
% of Holdings
1.4%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
3,500
Price
$181.33
Total Value
$634.66K
Shares Held After
174,134
% of Holdings
2.0%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,193
Price
$104.27
Total Value
$228.66K
Shares Held After
66,504
% of Holdings
3.2%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,500
Price
$180.36
Total Value
$450.89K
Shares Held After
177,634
% of Holdings
1.4%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
291
Price
$183.08
Total Value
$53.28K
Shares Held After
93,800
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
1,909
Price
$182.58
Total Value
$348.54K
Shares Held After
94,091
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,000
Price
$181.40
Total Value
$362.79K
Shares Held After
96,000
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,000
Price
$180.35
Total Value
$360.69K
Shares Held After
98,000
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chen Wan-Shan — Director
Shares
1,100
Price
$180.43
Total Value
$198.47K
Shares Held After
9,096
% of Holdings
10.8%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.41
Total Value
$14.10K
Shares Held After
13,586,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,576,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,566,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
5,000
Price
$1.43
Total Value
$7.15K
Shares Held After
13,556,890
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,551,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
5,240
Price
$1.43
Total Value
$7.49K
Shares Held After
13,541,890
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,536,650
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
20,000
Price
$1.43
Total Value
$28.60K
Shares Held After
13,526,650
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
4,760
Price
$1.44
Total Value
$6.85K
Shares Held After
13,506,650
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.44
Total Value
$14.40K
Shares Held After
13,501,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
500,000
Price
$1.44
Total Value
$720.00K
Shares Held After
13,491,890
% of Holdings
3.7%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
105,000
Price
$1.46
Total Value
$153.30K
Shares Held After
12,991,890
% of Holdings
0.8%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
886,890
Price
$1.43
Total Value
$1.27M
Shares Held After
12,886,890
% of Holdings
6.9%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
886,890
Price
$1.43
Total Value
$1.27M
Shares Held After
12,886,890
% of Holdings
6.9%
908 Devices Inc. (MASS)
McCallion Kevin J. — SVP, Products and Production
Shares
5,420
Price
$7.03
Total Value
$38.10K
Shares Held After
44,925
% of Holdings
10.8%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
7,392
Price
$7.04
Total Value
$52.04K
Shares Held After
963,137
% of Holdings
0.8%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
14,500
Price
$3.38
Total Value
$49.01K
Shares Held After
518,622
% of Holdings
2.7%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
135,201
Price
$16.59
Total Value
$2.24M
Shares Held After
3,936,436
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
162
Price
$582.30
Total Value
$94.33K
Shares Held After
18,876
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,756
Price
$580.64
Total Value
$1.02M
Shares Held After
19,038
% of Holdings
8.4%
Showing 301–350 of 1006 transactions (page 7 of 21)